BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Press Releases

  Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins

  July 17, 2024

   · 

  3 min read
• Press Releases

  CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

  July 17, 2024

   · 

  9 min read
• Press Releases

  BioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal Application

  July 17, 2024

   · 

  4 min read
• Press Releases

  HotSpot Therapeutics to Present Initial First-in-Human Phase 1 Clinical Data on its Novel CBL-B Inhibitor, HST-1011, at ESMO Congress 2024

  July 17, 2024

   · 

  1 min read
• Press Releases

  Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology

  July 17, 2024

   · 

  4 min read
• Press Releases

  AI Tool Successfully Responds to Patient Questions in Electronic Health Record

  July 17, 2024

   · 

  4 min read
• Press Releases

  Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - July 16, 2024

  July 17, 2024

   · 

  1 min read
• Press Releases

  Endo USA, Inc. Issues Voluntary, Nationwide Recall of One Lot of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Lot Number 550147301 Due to Mislabeling: Incorrect Strength on Product Carton

  July 17, 2024

   · 

  5 min read
• Press Releases

  GCCL Completes Proactive Development of Biosimilar Clinical Trial Analysis Methods, Providing Customized Analysis Services through Enhanced R&D Capabilities

  July 17, 2024

   · 

  3 min read
• Press Releases

  [Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity

  July 17, 2024

   · 

  9 min read